This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sarkar R, Chugh S, Garg VK. Newer and upcoming therapies for melasma. Indian J Dermatol Venereol Leprol. 2012;78(4):417–28.
Khan A, Yasir M, Asif M, Chauhan I, Singh A, Sharma R, et al. Iontophoretic drug delivery: history and applications. J App Pharm Sci. 2011;1(3):11–24.
Rawat S, Vengurlekar S, Rakesh B, Jain S, Srikarti G. Transdermal delivery by iontophoresis. Indian J Pharm Sci. 2008;70(1):5–10.
Rukari TG, Alhat BR. Iontophoresis: an electrically assisted drug delivery system. J Adv Drug Deliv. 2014;1(1):58–70.
Taylor MB, Yanaki JS, Draper DO, Shurtz JC, Coglianese M. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen. J Drugs Dermatol. 2013;12(1):45–50.
Huh CH, Seo KI, Park JY, Lim JG, Eun HC, Parl KC. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatol. 2003;206(4):316–20.
Choi YK, Rho YK, Yoo KH, Lim YY, Li K, Kim BJ, et al. Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo. Int J Dermatol. 2010;49(2):218–26.
Yoo JM, Park HJ, Choi SW, Kim HO. Vitamin C – iontophoresis in melasma. Korean J Dermatol. 2001;39(3):285–91.
Kim S, Oh SY, Lee SH. Comparative study of glycolic acid peeling vs. Vitamin C-iontophoresis in melasma. Korean J Dermatol. 2001;39(12):1356–63.
Sobhi RM, Sobhi AM. A single-blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma. J Cosmet Dermatol. 2012;11(1):65–71.
Handog EB, Datuin MS, Singzon IA. An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent in Filipino women. Int J Dermatol. 2016;55(2):153–7.
Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, et al. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Derm Surg. 2006;32:626–31.
Tse TW, Hui E. Tranexamic acid: an important adjuvant in the treatment of melasma. J Cosmet Dermatol. 2013;12(1):57–66.
Cho HH, Choi M, Cho S, Lee JH. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser. J Dermatolog Treat. 2013;24(4):292–6.
Malathi M, Thappa DM. Systemic skin whitening/lightening agents: what is the evidence? Indian J Dermatol Venereol Leprol. 2013;79(6):842–6.
Budamakuntla L, Loganathan E, Suresh DH, Shanmugam S, Suryanarayan S, Dongare A, et al. A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma. J Cutan Aesthet Surg. 2013;6(3):139–43.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer India
About this chapter
Cite this chapter
Datuin, M.S.L. (2017). Iontophoresis and Mesotherapy in Melasma. In: Handog, E., Enriquez-Macarayo, M. (eds) Melasma and Vitiligo in Brown Skin. Springer, New Delhi. https://doi.org/10.1007/978-81-322-3664-1_17
Download citation
DOI: https://doi.org/10.1007/978-81-322-3664-1_17
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-3662-7
Online ISBN: 978-81-322-3664-1
eBook Packages: MedicineMedicine (R0)